Guardant Health, Inc.
GH Nasdaq
SEC CIK 1576280
Follow Guardant Health
Weekly email: filings, results
Revenue, last quarter
$361M
+36.1% vs same quarter last year
Net income
−$124.4M
−34.1% vs same quarter last year
EPS, diluted
−$0.93
−25.7% vs same quarter last year
Operating cash flow
−$23.7M
+33.1% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $982M | −$416.3M |
| FY24 | $739M | −$436.4M |
| FY23 | $563.9M | −$479.4M |
| FY22 | $449.5M | −$654.6M |
| FY21 | $373.7M | −$384.8M |
| FY20 | $286.7M | −$246.3M |
| FY19 | $214.4M | −$75.7M |
| FY18 | $90.6M | −$85.1M |
| FY17 | $49.8M | −$83.2M |
| FY16 | $25.2M | −$46.1M |
| FY15 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 64.5% | −44.5% | −42.4% |
| FY24 | 60.8% | −60% | −59.1% |
| FY23 | 59.7% | −100.1% | −85% |
| FY22 | - | −121.1% | −145.6% |
| FY21 | - | −110% | −103% |
| FY20 | - | −88.9% | −85.9% |
| FY19 | - | −38.4% | −35.3% |
| FY18 | - | −102.5% | −93.8% |
| FY17 | - | −153.7% | −167% |
| FY16 | - | −173.7% | −182.7% |
| FY15 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$233.1M |
| FY24 | −$274.9M |
| FY23 | −$345.5M |
| FY22 | −$386.9M |
| FY21 | −$284.1M |
| FY20 | −$140.1M |
| FY19 | −$65.9M |
| FY18 | −$92.4M |
| FY17 | −$78.9M |
| FY16 | −$38.5M |
| FY15 | - |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | $45M |
| FY24 | $0 |
| FY23 | $0 |
| FY22 | - |
| FY21 | - |
| FY20 | $0 |
| FY19 | $0 |
| FY18 | $172K |
| FY17 | $7.2M |
| FY16 | $100K |
| FY15 | - |
- Guardant Health
- Healthcare median
Show the numbers
| Year | Guardant Health | Healthcare median |
|---|---|---|
| FY25 | −42.4% | −30.6% |
| FY24 | −59.1% | −47% |
| FY23 | −85% | −58% |
| FY22 | −145.6% | −80.4% |
| FY21 | −103% | −71.9% |
| FY20 | −85.9% | −62.2% |
| FY19 | −35.3% | −46.3% |
| FY18 | −93.8% | −49.6% |
| FY17 | −167% | −45.9% |
| FY16 | −182.7% | −36% |
| FY15 | - | −38.4% |